Question 1

Does Wasatch Advisors own KYMR stock?

Accepted Answer

No. Wasatch Advisors exited its KYMR (Kymera Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 572,907 shares worth $8M.

Question 2

How many shares of KYMR does Wasatch Advisors own?

Accepted Answer

None since Q4 2023, when Wasatch Advisors exited the position. Its Q3 2023 13F listed 572,907 shares worth $8M.

Question 3

What is Wasatch Advisors' KYMR position worth?

Accepted Answer

Wasatch Advisors' KYMR position was worth $8M in its Q3 2023 13F, before the exit in Q4 2023.

Question 4

Is Wasatch Advisors buying or selling KYMR?

Accepted Answer

In Q4 2023, Wasatch Advisors exited its entire KYMR position.

Question 5

When did Wasatch Advisors first buy KYMR?

Accepted Answer

Wasatch Advisors first reported KYMR in its Q2 2021 13F and listed it in 10 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2023-Q4 Latest	Exited	0	-100.0%	$0	0.0%	$25.46	0
2023-Q3	Decreased	572,907	-52.2%	$8M	0.1%	$13.90	0
2023-Q2	Increased	1.2M	+15.6%	$27.6M	0.2%	$22.99	40
2023-Q1	Increased	1M	+24.7%	$30.7M	0.2%	$29.63	42
2022-Q4	Decreased	832,221	-21.5%	$20.8M	0.1%	$24.96	0
2022-Q3	Increased	1.1M	+85.8%	$23.1M	0.2%	$21.77	53
2022-Q2	Increased	570,644	+140.4%	$11.2M	0.1%	$19.69	45
2022-Q1	Decreased	237,357	-1.5%	$10M	0.0%	$42.32	0
2021-Q4	Decreased	240,951	-0.2%	$15.3M	0.1%	$63.49	0
2021-Q3	Increased	241,366	+0.9%	$14.2M	0.1%	$58.74	28
2021-Q2	New	239,102	-	$11.6M	0.0%	$48.50	39